GALECTO

Galecto develops small molecules for the treatment of severe diseases, including fibrosis and cancer. The company lead product candidate, GB0139, is an inhaled inhibitor of galectin-3. GB0139 is being developed for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, in which there is high unmet medical need. Galecto was founded in 2011, builds on more than 10 years of research centering on the role of galectin-3 and LOXL-2, and the use of modulators of these proteins to treat fibrosis-related diseases and cancer. Combined with a strong patent estate, these assets give Galecto a unique therapeutic platform.

#SimilarOrganizations #People #Financial #Website #More

GALECTO

Social Links:

Industry:

Biotechnology Health Care Health Diagnostics

Founded:

2011-01-01

Address:

Copenhagen, Hovedstaden, Denmark

Country:

Denmark

Website Url:

http://www.galecto.com

Total Employee:

11+

Status:

Active

Email Addresses:

[email protected]

Total Funding:

160.41 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome IPv6 ReCAPTCHA

Similar Organizations

aura-biosciences-logo

Aura Biosciences

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

cg-oncology-logo

CG Oncology

CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

ribon-therapeutics-logo

Ribon Therapeutics

Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.

palisade-bio-logo

Palisade Bio

Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.

Current Advisors List

erez-chimovits_image

Erez Chimovits Board of Directors @ Galecto
Board_member

søren-møller_image

Søren Møller Board Member @ Galecto
Board_member

hans-schambye_image

Hans Schambye CEO @ Galecto
Board_member

david-shapiro_image

David Shapiro Board Member @ Galecto
Board_member

anne-prener_image

Anne Prener Board Member @ Galecto
Board_member
2021-01-01

chau-khuong_image

Chau Khuong Board of Directors @ Galecto
Board_member

chandra-leo_image

Chandra Leo Board of Directors @ Galecto
Board_member

carl-goldfischer_image

Carl Goldfischer Board Member @ Galecto
Board_member

Current Employees Featured

not_available_image

Lise Gravelle
Lise Gravelle CMC Director @ Galecto
CMC Director

not_available_image

Karen Killerup Poulsen
Karen Killerup Poulsen Regulatory Affairs Associate Director @ Galecto
Regulatory Affairs Associate Director

not_available_image

Frederik Zetterberg
Frederik Zetterberg Director, Medicinal Chemistry @ Galecto
Director, Medicinal Chemistry

not_available_image

Jie Wang-Jairaj
Jie Wang-Jairaj Medical Director @ Galecto
Medical Director

not_available_image

Anne Brinch
Anne Brinch Director of Clinical Operations @ Galecto
Director of Clinical Operations

not_available_image

Kim Vilbour Andersen
Kim Vilbour Andersen Director, Discovery @ Galecto
Director, Discovery

not_available_image

Catherine McClinton
Catherine McClinton Director of Clinical Operations @ Galecto
Director of Clinical Operations

not_available_image

Mike Gray
Mike Gray Director of Project Management @ Galecto
Director of Project Management

not_available_image

Patrick Alexander Dirchsen
Patrick Alexander Dirchsen Group Finance Director @ Galecto
Group Finance Director

not_available_image

Susan Tantawi
Susan Tantawi Director, Nonclinical Development @ Galecto
Director, Nonclinical Development

Founder

not_available_image

Hakon Leffler

hans-schambye_image

Hans Schambye

not_available_image

Tariq Sethi

not_available_image

Ulf Nilsson

Stock Details

Company's stock symbol is NASDAQ:GLTO

Investors List

janus-henderson-investors_image

Official Site Inspections

http://www.galecto.com Semrush global rank: 3.49 M Semrush visits lastest month: 4.29 K

Host Informations
Whois Informations

Loading ...